The assumption would be a quicker to market opportunity going down the cardio protective road…. And also keeping Big Pharma happy as their existing drug are able to make sales rather than trying to fight them to market with the FDA
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220, page-86
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.48 |
Change
-0.045(2.95%) |
Mkt cap ! $257.4M | |||
| Open | High | Low | Value | Volume |
| $1.55 | $1.55 | $1.45 | $224.9K | 151.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 10322 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 100 | 1 |
View Market Depth
| Last trade - 15.55pm 21/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |